Related Experiment Video
Updated: Jul 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh
W Abdullah Brooks1, Robert F Breiman, Doli Goswami
1ICDDR,B, Mohakhali, Dhaka, Bangladesh. abrooks@icddrb.org
Insights
Invasive pneumococcal disease (IPD) surveillance in Bangladesh revealed high incidence and significant antimicrobial resistance in children under five. Conjugate vaccines are expected to reduce IPD, pneumonia, and resistance.
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- Invasive pneumococcal disease (IPD) poses a significant threat to young children globally.
- Population-based data on IPD incidence, serotype distribution, and antimicrobial resistance in Bangladesh were previously lacking.
- Understanding these factors is crucial for public health interventions.
Purpose of the Study:
- To determine the incidence and serotype distribution of IPD in children under five years old in urban Bangladesh.
- To describe the clinical presentation and antimicrobial resistance patterns of IPD.
- To evaluate the potential impact of conjugate vaccines on IPD and related outcomes.
Main Methods:
- Active, population-based surveillance was conducted in 5,000 urban households.
- Blood cultures were collected from eligible children aged <5 years between April 2004 and March 2006.
- Isolation of Streptococcus pneumoniae and antimicrobial susceptibility testing were performed.
Main Results:
- A total of 34 cases of IPD were identified among 6,167 eligible children.
- Overall IPD incidence was 447 episodes/100,000 child-years, with 13-valent serotype-related IPD incidence at 276 episodes/100,000 child-years.
- High rates of resistance were observed for cotrimoxazole (82.4%), ciprofloxacin (24.1%), and chloramphenicol (14.7%).
Conclusions:
- IPD incidence, particularly related to vaccine serotypes, is substantial in young Bangladeshi children.
- High antimicrobial resistance necessitates careful treatment strategies and highlights the importance of vaccination.
- Current conjugate vaccines are anticipated to significantly decrease IPD, childhood pneumonia, and antimicrobial resistance in Bangladesh.
Abstract:
We undertook active population-based surveillance in 5,000 urban households among children < 5 years old to determine invasive pneumococcal disease (IPD) incidence, serotype distribution, clinical presentation, and antimicrobial resistance, which have not been previously described in population-based studies from the region. IPD was documented by blood culture isolation. From 01 April 2004 to 31 March 2006, 5,903 blood cultures were collected from 6,167 eligible children. Streptococcus pneumoniae was isolated from 34 pneumococcal patients; IPD was clinically associated with pneumonia (24%), upper respiratory infection (62%), and febrile syndromes (14%). Overall, IPD and 13-valent serotype-related IPD incidences were 447 and 276 episodes/100,000 child-years, respectively. Peak IPD incidence occurred during the cool dry seasons. Penicillin, cotrimoxazole, chloramphenicol, and ciprofloxacin resistances were 2.9%, 82.4%, 14.7%, and 24.1%, respectively. Current conjugate vaccines should substantially reduce IPD, childhood pneumonia, and antimicrobial resistance in Bangladesh.
Related Concept Videos
Bacterial Meningitis I: Introduction
Smallpox
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Bacterial Meningitis II: Pathophysiology

